Wikipedia -WSS

Wikipedia

author：leisure time 2025-08-28 06:23:51 - browse：7827

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： France's anti

focus

WSS

Why did Pfizer dish out millions for a Super Bowl ad?

PhRMA lawsuit over Medicare drug price negotiation tossed

Companies helping big Covid

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Vaccine advisory panel ACIP left half staffed by HHS

entertainment

Wikipedia

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Gilead might be held responsible for not developing a drug

Anesthesiologist group: stop taking Ozempic before surgery

Gilead might be held responsible for not developing a drug

Bright Health sells Medicare Advantage business to Molina

The Readout: Gilead, Bernie Sanders, and other pharma news

At least 13 dead in Texas as scorching temps continue

BioAge raises $170M for combination therapy with Zepbound

Tori Bowie and the unacceptable rates of Black maternal death

After half a century, Israel moves to evict squatter from his cave home on the beach

Wikipedia

Watch the official trailer for 'Ahsoka' series

Medical mystery: When a cough is not just a cough

Industry veterans launch new biotech VC with $310M

For Medicare Advantage, Democrats want stronger protections around AI

Why did Pfizer dish out millions for a Super Bowl ad?

To avoid data mishandling cases, universities eye AI and other tools

focus

focus

focus

focus